Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men

Journal of Clinical Endocrinology and Metabolism

Volumn 66, Issue 1, 1988, Pages 57-61

  Nestler, John E ^a   Barlascini, Cornelius O ^a   Clore, John N ^a   Blackard, William G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; LOW DENSITY LIPOPROTEIN; PRASTERONE; TESTOSTERONE;

ADULT; BODY FAT; CLINICAL ARTICLE; HUMAN; INSULIN SENSITIVITY; MALE; MUSCLE MASS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

ADIPOSE TISSUE; ADULT; ANDROGENS; ANDROSTENEDIONE; BODY COMPOSITION; CHOLESTEROL; DEHYDROEPIANDROSTERONE SULFATE; HUMAN; INSULIN; LIPIDS; LIPOPROTEINS, LDL; LIPOPROTEINS, LDL CHOLESTEROL; MALE; MUSCLES; PRASTERONE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023838538     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-66-1-57     Document Type: Article

References (17)

1. Schwartz AG 1979 Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res 39:1129
2. Ben-David M, Dikstein S, Bismuth G, Sulman FG 1967 Anti-hypercholesterolemic effect of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med 125:1136
3. Coleman DL, Leiter EH, Schwizer RW 1982 Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31:830
4. Coleman DL, Schwizer RW, Leiter EH 1984 Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Diabetes 33:26
5. Parker Jr CR, Simpson ER, Bilheimer DW, Leveno K, Carr BR, MacDonald PC 1980 Inverse relation between low-density lipoprotein-cholesterol and dehydroepiandrosterone sulfate in human fetal plasma. Science 208:512
6. Barrett-Connor E, Khaw K-T, Yen SSC 1986 A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315:1519
7. Nestler JE, Clore JN, Strauss III JF, Blackard WG 1987 The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 64:180
8. Rizza RA, Mandarino LJ, Gerich JE 1981 Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240:E630
9. Behnke AR, Feen BG, Welham WC 1942 The specific gravity of healthy men. JAMA 118:495
10. Siri WE 1961 Body composition from fluid spaces and density. Analysis of methods. In Brozek J, Henschel A (eds) Proceedings of the Conference, January 22-23, 1959, National Academy of Sciences. National Research Council, Washington DC, p 223
11. Morgan CR, Lazarow A 1963 Immunoassay of insulin: two antibody system. Diabetes 12:115
12. Resko JA, Ellinwood WE, Pasztor LM, Buhl AE 1980 Sex steroids in the umbilical circulation of fetal rhesus monkeys from the time of gonadal differentiation. J Clin Endocrinol Metab 50:900
13. Plymate SR, Fariss BL, Bassett ML, Matej L 1981 Obesity and its role in polycystic ovary syndrome. J Clin Endocrinol Metab 52:1246
14. Pearlman WH, Measurement of testosterone binding sites. Karo-linska Symposia on Research Methods in Reproductive Endocrinology, Huddinge, Sweden, Second Symposium, 1970, Vol 2:225
15. Segal P, Bachorik P, Rifkind B, Levy R 1984 Lipids and dyslipo-proteinemia. In Henry RB (ed) Clinical Diagnosis and Management by Laboratory Methods. Saunders, Philadelphia, p 186
16. Kent S 1982 DHEA: “miracle” drug? Geriatrics 37:157
17. Mooradian AD, Morley JE, Korenman SG 1987 Biological actions of androgens. Endocr Rev 8:1